- Home
- ONC vs KR Comparison
ONC vs KR Comparison
Compare ONC & KR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONC | KR |
|---|---|---|
| Founded | 2010 | 1883 |
| Country | Switzerland | United States |
| Employees | 12000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 37.1B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | ONC | KR |
|---|---|---|
| Price | $322.01 | $57.64 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $385.10 | $74.25 |
| AVG Volume (30 Days) | 354.8K | ★ 7.2M |
| Earning Date | 05-06-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 2.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | N/A | ★ $147,642,000,000.00 |
| Revenue This Year | $723.76 | $4.39 |
| Revenue Next Year | $15.04 | $2.30 |
| P/E Ratio | $614.06 | ★ $41.01 |
| Revenue Growth | N/A | ★ 0.35 |
| 52 Week Low | $253.95 | $54.15 |
| 52 Week High | $385.22 | $76.58 |
Technical Indicators
Market Signals| Indicator | ONC | KR |
|---|---|---|
| Relative Strength Index (RSI) | 67.74 | 53.68 |
| Support Level | $325.47 | $58.60 |
| Resistance Level | $328.39 | $64.44 |
| Average True Range (ATR) | 8.03 | 1.54 |
| MACD | 1.40 | 0.33 |
| Stochastic Oscillator | 87.66 | 78.14 |
Price Performance
Historical ComparisonAbout ONC BeiGene Ltd. American Depositary Shares
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
About KR Kroger Company (The)
Founded in 1883, Kroger is the largest pure-play supermarket operator in the United States, operating roughly 2,700 stores across more than 30 banners. Kroger's business is primarily grocery-led (roughly 78% of sales), spanning fresh food and private-label offerings, complemented by fuel centers (9%) and pharmacies (12%). The firm also generates income from advertising, data analytics, and manufacturing.